HACKETT LIMITED
Company number 01872280 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: N/A - Incomplete Data (Qualitative Health: B+)
Just as a physician cannot provide a clean bill of health without blood test results, a complete financial grading is impossible without the core financial statements (balance sheet, profit & loss). The "lab results" for turnover, assets, and liabilities are missing from the current file. However, based on the corporate metadata and compliance history available, the qualitative health of the business structure is a solid B+, indicating a long-standing, compliant, and operationally active entity.
2. Key Vital Signs
- Corporate Heartbeat (Longevity): Incorporated in 1984, the company has a 40-year operating history. In the volatile retail clothing sector, surviving for nearly four decades is the equivalent of a patient having excellent cardiovascular health—it shows resilience, adaptability, and enduring market demand.
- Compliance Pulse (Regulatory Health): All statutory filings are up to date, with accounts made up to March 2025 and no overdue flags. This indicates a healthy administrative pulse with no symptoms of regulatory distress or administrative neglect.
- Baseline Weight (Share Capital): The issued share capital stands at a remarkably low £48. For a well-known Savile Row retail brand filing "Full" (unabridged) accounts, this is a classic symptom of a mature, profitable enterprise. It suggests that over the decades, the business has successfully distributed its retained profits as dividends to shareholders rather than keeping them locked in the share capital, keeping the legal "baseline weight" at a minimum.
- Missing Vitals (Financial Metrics): Critical metrics such as the Current Ratio (liquidity), Gearing (leverage), and Profit Margins are currently unreadable. Without these, we cannot measure the company's "cholesterol" (debt levels) or "blood oxygen" (cash flow availability).
3. Diagnosis
Based on the visible symptoms, Hackett Limited presents as a structurally sound and historically robust corporate entity, though its underlying financial fitness remains obscured.
The absence of named individuals on the People with Significant Control (PSC) register—replaced instead by a generic PSC statement—strongly suggests that the ultimate ownership resides within a corporate hierarchy (such as a holding company or private equity fund). This means Hackett Limited's financial "immune system" and daily nutritional needs (cash flow and working capital) are likely heavily intertwined with its parent group.
The change of name from Gillywest Limited back in 1992 marks a successful corporate "surgery" early in its lifecycle, rebranding to the now globally recognised Hackett label. Today, the patient is active, out of the intensive care unit (not in liquidation or administration), and supported by a robust board of five directors, including international representation which aligns with a global retail brand.
4. Recommendations
- Request Full Lab Work: To accurately diagnose financial wellness, the full annual accounts (balance sheet, profit & loss, and cash flow statement) must be reviewed. This will reveal whether the business is generating healthy cash flow or masking symptoms of distress with debt.
- Monitor Sector-Specific Infections: The UK retail clothing sector (SIC 47710) is highly susceptible to "seasonal infections" (cash flow dips due to slow-moving stock) and "environmental shocks" (cost-of-living crises reducing footfall). Management should maintain strong working capital reserves to inoculate the business against these risks.
- Review Group Dynamics: Given the likely corporate PSC structure, any assessment of Hackett Limited's health must include a check on the parent company. Inter-company loans often act as the circulatory system for group entities; if the parent company bleeds cash, the subsidiary can quickly suffer from financial anemia.